Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (1y) (2010 - 2026)

Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (1y) (Qtr)
1	Abbott Laboratories	199.45 Bn	193.85 Bn	7.27 Bn	-562.77%
2	Stryker	127.62 Bn	124.14 Bn	4.50 Bn	2,827.78%
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn	10.50%
4	Boston Scientific	73.41 Bn	72.87 Bn	3.85 Bn	-395.56%
5	Edwards Lifesciences	51.89 Bn	47.64 Bn	1.35 Bn	168.38%
6	Dexcom	34.33 Bn	32.38 Bn	830.00 Mn	-103.49%
7	GE HealthCare Technologies	33.87 Bn	31.76 Bn	2.18 Bn	-114.85%
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn	-215.59%
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn	-54.17%
10	Zimmer Biomet Holdings	19.24 Bn	18.83 Bn	1.54 Bn	98.33%

Download Data